ANNA TOBIN: Open Payments
NPI 1033735709 · CLARKSTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$675 in 36 payments from 13 companies in 2025. Trend: 2023 $167 · 2024 $594 · 2025 $675
Food & beverage: $675
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $209 |
| Novo Nordisk Inc | 6 | $107 |
| Astellas Pharma US Inc | 4 | $75 |
| Lilly USA, LLC | 3 | $57 |
| PFIZER INC. | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $20 |
Products named: UBRELVY, Veozah, MOUNJARO, Rybelsus, Wegovy, REXULTI, Kerendia, BREZTRI.
Industry payments across MI — which companies pay providers there.
